Insulet CorporationPODDNASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Analyst Sentiment

Analysts lean bullish — 96% recommend buying.

Consensus Rating

Buy

24 analysts·High coverage

96%

Rating Distribution

Strong Buy

00%

Buy

2396%

Hold

00%

Sell

14%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 57% higher.

Bear Case

$286.00

+26%

Consensus

$357.25

+57%

Bull Case

$435.00

+92%

Price Range24 analysts

Low

Consensus

High

$286.00

$435.00

Current Target

Current Price

$227.10

Upside to Target

$130.15

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$6.34(15 analysts)

P/E65x

Current: 65.1x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+19.42%

EPS+27.86%

FY2028

Rev+18.46%

EPS+25.91%

FY2029

Rev+17.78%

EPS+25.33%

Earnings Surprises

Beat rate:92%(11/12 quarters)

Avg surprise:+48.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 19, 2026Truist Financial

Insulet price target lowered to $360 from $390 at Truist

Target:$360.00

+46.3%from $246.04

Feb 19, 2026Evercore ISI

Insulet price target lowered to $340 from $370 at Evercore ISI

Target:$340.00

+35.3%from $251.21

Feb 19, 2026Goldman Sachs

Insulet price target lowered to $326 from $363 at Goldman Sachs

Target:$326.00

+29.7%from $251.38

Feb 19, 2026Oppenheimer

Insulet price target lowered to $300 from $365 at Oppenheimer

Target:$300.00

+17.8%from $254.59

Feb 19, 2026Bernstein

Insulet price target lowered to $330 from $380 at Bernstein

Target:$330.00

+27.9%from $258.07

Feb 19, 2026Barclays

Insulet price target raised to $286 from $274 at Barclays

Target:$286.00

+10.8%from $258.07

Feb 18, 2026Canaccord Genuity

Insulet Corporation (PODD) PT Lowered to $435 at Canaccord Genuity

Target:$435.00

+68.6%from $258.07

Feb 4, 2026Stifel Nicolaus

Insulet price target lowered to $350 from $370 at Stifel

Target:$350.00

+40.5%from $249.07

Jan 12, 2026Barclays

Insulet downgraded to Underweight from Equal Weight at Barclays

Target:$274.00

-4.5%from $286.92

Jan 9, 2026Bernstein

Insulet price target lowered to $380 from $410 at Bernstein

Target:$380.00

+29.7%from $292.89

Jan 9, 2026Goldman Sachs

Insulet price target lowered to $365 from $388 at Goldman Sachs

Target:$365.00

+24.6%from $292.89

Dec 18, 2025Truist Financial

Insulet price target lowered to $390 from $412 at Truist

Target:$390.00

+31.6%from $296.42

Dec 17, 2025Canaccord Genuity

Insulet price target raised to $450 from $432 at Canaccord

Target:$450.00

+55.9%from $288.73

Dec 16, 2025Evercore ISI

Insulet initiated with an Outperform at Evercore ISI

Target:$370.00

+25.3%from $295.31

Nov 24, 2025Canaccord Genuity

Insulet price target raised to $432 from $428 at Canaccord

Target:$432.00

+30.4%from $331.17

Nov 21, 2025Truist Financial

Insulet price target raised to $412 from $390 at Truist

Target:$412.00

+26.8%from $325.00

Nov 21, 2025RBC Capital

Insulet price target raised to $380 from $370 at RBC Capital

Target:$380.00

+17.2%from $324.19

Nov 21, 2025BTIG

Insulet price target raised to $380 from $370 at BTIG

Target:$380.00

+21.4%from $312.89

Nov 19, 2025UBS

Insulet upgraded to Buy from Neutral at UBS

Target:$400.00

+20.0%from $333.47

Nov 6, 2025Jefferies

Insulet Corporation (PODD) PT Raised to $400 at Jefferies

Target:$400.00

+23.7%from $323.40

Nov 6, 2025BTIG

BTIG Reiterates Buy Rating on Insulet Corporation (PODD)

Target:$370.00

+14.4%from $323.40

Nov 5, 2025Barclays

Insulet price target raised to $301 from $300 at Barclays

Target:$301.00

-6.0%from $320.27

Oct 10, 2025RBC Capital

Insulet price target raised to $365 from $350 at RBC Capital

Target:$365.00

+14.8%from $318.00

Sep 29, 2025Canaccord Genuity

Insulet price target raised to $399 from $353 at Canaccord

Target:$399.00

+25.5%from $318.00

Apr 28, 2025Wells Fargo

Wells Fargo sees new CEO appointment as 'significant positive' for Insulet

Target:$322.00

+24.1%from $259.52

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance